The Latest Breaking News from Takeda

Gabriele Ricci, chief data and technology officer, has been reorganizing the technology function at Takeda Pharmaceutical.

Helen Giza of FME is excited about the possibilities new drugs such as Ozempic could offer for renal patients

Exclusive: contaminated blood campaigners say internal 1976 Immuno AG document proves British government negligence

Takeda and Hyderabad-based vaccine maker Biological E. have formed a strategic partnership to accelerate access to the Japanese firm’s QDENGA dengue vaccine (TAK-003) multi-dose vials.

The outsourcing sector is well-placed to thrive due to its ability to provide cost-effective solutions, access to specialized skills, focus on core business activities, and enhanced productivity. Therefore, it could be wise to invest in quality outsourcing stocks Cognizant (CTSH), Stride (LRN), and Barrett Business Services (BBSI) for substantial gains.…

Drugs regulator Drugs Controller General of India has directed States and Union Territories to keep vigil on sale and distribution of falsified versions of two drugs, liver medication Defitelio and Takeda’s cancer drug Adcetris after alerts from World Health Organization

Takeda Pharmaceutical chief digital trust officer Mike Towers says his industry has been slow to adapt, but is accelerating fast.

Earlier this year, federal health minister Mark Butler announced a new national Lung Cancer Screening Program. The first of its kind for lung cancer, the screening program will open initially to current and former smokers aged 50 to 70 years by July 2025. It aims to save lives by detecting…

Brits planning to travel abroad are being warned about the risks of potentially deadly dengue fever - a disease spread by Asian tiger mosquitoes and which has been detected in the likes of Ibiza and southern France